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Malaria epidemics affect nonimmune populations 
in many highland and semi-arid areas of Africa. Effective 
prevention of these epidemics is challenging, particularly 
in the highlands where predictive accuracy of indicators is 
not sufﬁ  ciently high to allow decisions involving expensive 
measures such as indoor residual spraying of insecticides. 
Advances in geographic information systems have proved 
useful in stratiﬁ  cation of areas to guide selective targeting 
of interventions, including barrier application of insecticides 
in transmission foci to prevent spread of infection. Because 
rainfall is associated with epidemics in semi-arid areas, ear-
ly warning methods based on seasonal climate predictions 
have been proposed. For most areas, response measures 
should focus on early recognition of anomalies and rapid 
mass drug administration. Vector control measures are use-
ful if abnormal transmission is highly likely and if they can be 
selectively implemented at the early stages of an outbreak.
M
alaria epidemics frequently affect highlands and 
semi-arid areas where populations lack immunity. 
Rapid response to these epidemics can be made where ef-
fective surveillance systems are in place for early recog-
nition of disease incidence anomalies. Recent advances in 
research on malaria early warning systems are potentially 
useful to reduce the effects of epidemics, but they are asso-
ciated with challenges that face most developing countries. 
Here, different intervention decisions will be discussed 
within the context of research ﬁ  ndings relevant to epidemic 
malaria and implementation capacities of epidemic-prone 
countries.
Highlands and Semi-arid Areas
Most malaria epidemics follow abnormal weather con-
ditions, often in combination with other causes, including 
increased resistance of the parasite to antimalarial drugs, 
population movement due to seasonal labor and civil un-
rest, and reduced malaria control operations, in particular, 
the cessation of regular vector control (1).
In highlands, transmission is unstable due to ﬂ  uctua-
tions in temperatures that are normally low (2). Tempera-
ture affects duration of the sporogonic cycle of the Plas-
modium parasite within the Anopheles vector, survival and 
feeding frequency of the adult female, and duration of the 
aquatic stages. Most of the epidemics affecting highlands 
that support short, annual, transmission are superimposed 
over normal seasonal increases in malaria incidence, a phe-
nomenon that makes early detection difﬁ  cult. Other areas 
experience occasional transmission in speciﬁ  c years with 
more pronounced levels of illness and death, and substan-
tial spatial and temporal variations (3). In addition to ex-
plosive epidemics, highland areas in Africa have shown 
a trend of increasing malaria transmission in recent years 
(4). This trend has important implications for choosing re-
sponse mechanisms.
Semi-arid areas, on the other hand, have mostly warm 
climates, and epidemics are associated with anomalous 
rainfall, which causes increases in vector breeding and sur-
vival. In Botswana, more than two thirds of the variability 
observed between years in malaria incidence during Janu-
ary–May could be explained by variation in rainfall during 
December–February (5). A major epidemic that affected 
semi-arid regions of northeastern Kenya in January–May 
1998 was reportedly caused by abnormal rainfall and 
ﬂ  oods during November–December 1997 (6). In these ar-
eas, monitoring rainfall can provide a fairly accurate fore-
cast of transmission risk (5,7,8).
Preventive Interventions
The type and targets of interventions depend on the 
forecast probability, available resources, and the timing of 
the events or available lead time. In most cases, highly ac-
curate forecasting is not possible as yet (e.g., in highlands); 
hence, emphasis should be placed on improving surveil-PERSPECTIVE
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lance for early detection of abnormal incidence to mini-
mize delays in responding (9).
Malaria control programs are usually faced with uncer-
tainties regarding decisions on whether seasonal preventive 
measures should be used routinely in areas known to be at 
risk due to their geographic characteristics or whether de-
veloping mechanisms for rapid response is a better strategy. 
Although decisions have to be made rapidly in epidemic 
situations, they also have to be economically justiﬁ  able. 
Interventions that are appropriate in semi-arid areas can be 
difﬁ  cult to implement or may be less useful in highland 
situations. In particular, measures aiming at prevention are 
more suited to semi-arid areas and sometimes to highlands 
with moderate malaria endemicity, rather than to highlands 
that are normally malaria free and only occasionally af-
fected by epidemics.
In most highlands with substantial interannual variabil-
ity of incidence, measures such as regular indoor residual 
spraying (IRS) of insecticides for preventive purposes may 
be an unnecessary waste of resources. However, IRS on an 
annual basis may be justiﬁ  ed in some highland fringe ar-
eas. For example, in Madagascar, annual IRS was restored 
during 1993–1998 to reverse the spread of epidemic ma-
laria that reappeared following recolonization of the central 
highlands by A. funestus, which had disappeared after ef-
fective control campaigns (10,11). After 5 years of spray-
ing DDT mostly in areas between 1,000 m and 1,500 m in 
altitude, vector density and malaria prevalence rates were 
greatly reduced. Annual IRS campaigns in the 1950s in the 
epidemic-affected highlands of Kenya have also produced 
similar results (12,13). Selective application of insecticides 
for a limited number of years in areas most at risk for un-
stable transmission, followed by focal use as and when re-
quired, should be considered, especially in areas bordering 
malaria-endemic lowlands or in transmission foci in val-
leys in highland       regions.
Highland valleys are often the source of malaria infec-
tion. A survey in an altitudinal transect in the Usambara 
mountains in Tanzania has shown the importance of lo-
cal topography in explaining variations in splenomegaly 
among residents (14). Not surprisingly, altitude correctly 
predicted whether an occupant had an enlarged spleen in 
73% of households. Moreover, when land where water was 
likely to accumulate within 400 m of each household was 
included in the model, prediction signiﬁ  cantly improved 
in areas with an altitude from 1,000 to 1,200 m, where 
malaria transmission is unstable. In the western Kenyan 
highlands, the indoor density of A. gambiae s.s. vectors 
has been shown to be negatively associated with distance 
from swamps (15). Areas near man-made breeding sources 
also have high transmission risks. For example, human ac-
tivities such as brick making have played a role in creating 
vector-breeding sites during the dry seasons (16). A spatial 
analysis of the distribution of P. falciparum in the high-
lands of Kenya has indicated that prevalence of infection 
and parasite densities decreased with distance from valley 
bottoms (17). These foci maintain low levels of transmis-
sion through the dry periods and are a potential source of 
infection when weather and other conditions favor spread 
of the disease to surrounding highlands. Selective annual 
insecticide spraying of houses in and around these valley 
bottoms and areas in the vicinity of man-made transmission 
sources may help protect the populations in the highlands 
during transmission seasons. An effective insecticide with 
a long residual life (such as DDT) should be used. The po-
tential use of geographic information systems and remote 
sensing technologies to map transmission foci and risk fac-
tors and to guide targeting of interventions has been ex-
tensively reviewed (18). Spatial epidemic risk maps, based 
on the climate proﬁ  les of epidemic-affected localities, have 
been proposed for highland areas in the Horn of Africa and 
East Africa (2). Static spatial maps have been used for gen-
eral stratiﬁ  cation of areas and, in some cases, for regular 
interventions in countries such as Madagascar (10), South 
Africa (19), and India (20).
In the past few years, several international collabora-
tive efforts have been initiated to develop and test tem-
poral risk maps based on rainfall anomalies by using re-
mote sensing technologies, with special applicability in 
semi-arid areas (7). Continually updated rainfall anomaly 
maps are available free of charge from the websites of 
the Famine Early Warning Systems Africa Data Dissemi-
nation Service (http://igskmncnwb015.cr.usgs.gov/adds) 
and  the  International  Research  Institute  for  Climate  and               
Society (http://iridl.ldeo.columbia.edu/maproom/.Health/.
Regional/.Africa/.Malaria). The practical use of these 
technologies for early warning of abnormal transmission 
and selective application of prevention or preparedness 
is yet to be fully evaluated, although encouraging results 
have been documented in southern Africa, especially in 
Botswana (7). Because rainfall variability in Botswana 
has high predictability of interannual variations in malaria 
incidence (5), an early warning system has been proposed 
to provide probabilistic forecasts of anomalously high or 
low incidence in semi-arid areas on the basis of seasonal 
precipitation forecasts (8). Although claims have been 
made that the system can add up to 4 months of warn-
ing over methods that use observed precipitation, the 
system’s sustainable applicability for targeting preventive 
measures remains to be seen.
In the highlands, monitoring temperature anomalies 
can provide crude forecasts. Studies have shown that major 
epidemics in the 1980s and early 1990s in Ethiopia were 
signiﬁ  cantly more often preceded by a month of abnormal-
ly high minimum temperature than would be expected by 
random chance (3). Similarly, higher than average tempera-tures in Zimbabwe were associated with severity of epidem-
ics and deaths in the following year (21). Studies involving 
concomitant longitudinal follow-up of weather patterns, in-
door resting densities of vectors, and malaria incidence are 
ongoing in highland sites in Kenya and Uganda to clarify 
and quantify epidemic-triggering mechanisms (22).
Several studies have shown epidemic malaria to be as-
sociated with El Niño events in many parts of the world 
(23). For example, analysis of malaria data from Colom-
bia for 1980–1997 appears to indicate that El Niño events 
intensify the annual seasonal transmission cycle (24). 
Prediction based on El Niño indicators may prove useful 
for ensuring availability of resources at national levels, in 
particular, drugs and insecticides, because of the relatively 
long lead times (25).
Rapid Assessment
Early detection capacity is essential for effective and 
rapid containment of epidemics. An important aspect of 
such capacity is the existence of efﬁ  cient disease surveil-
lance systems. In East Africa, research has shown that com-
puter-assisted, weekly sentinel surveillance can be success-
fully implemented at district levels (22).
After detection of abnormal increases, mostly in-
creased numbers of clinically diagnosed cases, the actual 
causes of the increases should be rapidly conﬁ  rmed through 
laboratory diagnosis before intervention measures are rec-
ommended. Conﬁ  rmation should be followed by assessing 
the magnitude and geographic extent of the outbreak, pri-
oritizing areas, and deciding on the types of interventions 
required. These steps, however trivial they might seem, are 
nevertheless essential and must be taken within the shortest 
possible time. In most instances, simple rapid assessment 
methods are sufﬁ  cient for sound decisions. As an example, 
in an epidemic that affected Uasin Gishu District in Kenya, 
school absenteeism was used as an indicator to determine 
priority areas for mass treatment of fever (26).
More advanced techniques that are economical but 
powerful and rapid can also be implemented, especially if 
sampling procedures are adopted in advance of an epidemic 
event. One such technique is lot quality assurance sampling 
(LQAS). The LQAS method was ﬁ  rst used in industrial 
sampling to identify batches of products (or lots) with un-
acceptable number of defective items. In public health, this 
method has been used to select communities with disease 
prevalence rates beyond acceptable levels (27). Its advan-
tage is that relatively smaller sample sizes are required than 
in other sampling methods. After an acceptable probability 
of error and the maximum sample size are determined, the 
population is sampled until a certain number of infections 
is exceeded; the sampling then stops and the area is classi-
ﬁ  ed as having high prevalence. In Madagascar, this proce-
dure was compared with a conventional sampling plan to 
select areas where prevalence rates among schoolchildren 
were at least 15%; such areas were candidates for some 
speciﬁ  c action (28). A plan in which 2 persons were found 
positive among a random sample of 36, denoted as (36,2), 
classiﬁ  ed communities correctly with 100% sensitivity and 
94% speciﬁ  city. After such assessments, the use of IRS for 
epidemic control should only be considered if continua-
tion of transmission is anticipated over a long period and if 
rapid implementation of IRS is feasible at the early phase 
of an epidemic. The main challenge is that few countries 
have the capacity to rapidly organize and implement IRS as 
a meaningful epidemic-containment method.
Sufﬁ  cient evidence that insecticide-treated nets (ITNs) 
are beneﬁ  cial for short-term epidemic control is lacking, 
so their use should be limited to situations in which their 
availability and rapid implementation is possible, such as in 
refugee camps (25). Nevertheless, widespread use of ITNs 
in epidemic-prone areas with moderate malaria endemic-
ity will, in the long run, contribute to transmission reduc-
tion and should be encouraged. Larval control may have a 
limited role in some situations, for example, in semi-arid 
areas, with well-deﬁ  ned mosquito breeding sites after rainy 
periods, or in man-made sites such as wells and water stor-
age tanks. Larviciding is likely to be effective when bodies 
of water cannot be eliminated due to essential economic 
activities such as brick making (16).
Occasionally, widespread epidemics affect large geo-
graphic areas such as the highlands of Ethiopia, affected 
in 1988 (3). In such situations, carrying out large-scale 
preventive IRS operations would be difﬁ  cult, if not im-
possible, even if early warning systems are in operation. 
Health services need to focus on more feasible measures 
such as strengthening preparedness by stocking drugs and 
diagnostic materials, closely monitoring changes in malaria 
incidence, educating communities to seek prompt treat-
ment, classifying areas according to their risk levels, and 
making contingency plans to rapidly deploy mobile treat-
ment teams.
Mass Drug Administration and 
Mass Fever Treatment
Mass drug administration (MDA) is the presumptive 
treatment of an entire affected population with a therapeutic 
dose of an antimalarial drug, whereas mass fever treatment 
(MFT) refers to treatment of febrile patients only. These 
approaches require that sufﬁ  cient and appropriate antima-
larial agents are available and that mobile treatment teams 
can be deployed in affected areas in the shortest possible 
time. In all epidemic situations, rapid distribution of effec-
tive treatment in affected communities is recommended. 
This requires local surveillance and logistics capacity for 
early detection of abnormal incidence and timely mobiliza-
tion of resources.
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In areas where reliable early warning systems are not 
in place due to technical, logistical, or other reasons, stock-
ing contingency antimalarial drugs in health units across 
areas at risk before known transmission seasons provides 
an alternative approach. Epidemics tend to occur during 
those seasons of known transmission, which mostly follow 
the rainy period. Areas historically known to be most at risk 
should be identiﬁ  ed to prioritize health units for drug distri-
bution. If available, risk maps may be used for classiﬁ  cation 
of areas. A practical alternative for inter-area comparisons 
is to use proxy measures such as adult-to-child ratios of 
patients attending health facilities. This approach has been 
used in Kenya to study stability of malaria in the highlands 
(29). Malaria patients admitted to the hospital were classi-
ﬁ  ed into 2 age groups: <15 years of age (“children”) and 
>15 years (“adults”). Depending on the age structure of the 
developing country populations, the adult-to-child ratio of 
hospital admissions approached unity for an unstable ma-
laria situation in which adults were as likely as children to 
be at risk for severe malaria.
MDA has been used alone or in combination with 
IRS to prevent and control malaria in various settings. The 
primary objective of this measure in the epidemic con-
trol context is to reduce the reservoirs of the parasite by 
reducing infectiousness to vectors, while providing cura-
tive and prophylactic beneﬁ  ts to treated persons. To have 
the desired effects on transmission, antimalarial drugs with 
schizontocidal and gametocytocidal effects should be used. 
In the past, primaquine was given in combination with 4-
aminoquinolines for its effect on gametocytes. In a ma-
laria-endemic area in Tanganyika (present day mainland 
Tanzania), the repeated use of amodiaquine and primaquine 
combination considerably lowered transmission by reduc-
ing the sporozoite rates (30). Repeated MDA with progua-
nil has been shown to substantially reduce transmission 
in the highlands of western Kenya in the late 1940s (31). 
Although many MDA trials did not interrupt transmission, 
most succeeded in considerably reducing parasite preva-
lence, and some showed marked reduction in incidence of 
cases and deaths (32).
Alternatively use of MFT as an important rapid mea-
sure, rather than using MDA for the entire population, has 
been proposed for epidemic control (25). Attaining high 
coverage is crucial; epidemiologically relevant questions 
include the practicality of diagnosing fever cases in emer-
gency situations and whether a large enough proportion 
of the population can be treated in this way in order to 
have a considerable impact on transmission. In Ethiopia, 
the Ministry of Health guidelines recommend rapid sam-
pling of households to determine the proportion of occu-
pants with illness in the previous 7 days; a cut-off value 
of 50% would then be used to decide whether to use MFT 
or MDA (33).
The introduction of combination therapy with arte-
misinin derivatives, which have gametocytocidal effects, 
has recently led to the hypothesis that its use for large-
scale MDA might be a potential malaria control measure 
(32). Artemisinin-based combination therapy (ACT) drugs 
have been shown to moderately reduce transmission by 
reducing the duration of gametocyte carriage and the pro-
portion of mosquitoes that are infected by carriers (34). 
In The Gambia, children treated with the combination of 
chloroquine and artesunate were signiﬁ  cantly less infec-
tious to mosquitoes than children treated with chloroquine 
alone (35). Treatment with the combination containing 
artesunate also signiﬁ  cantly reduced the prevalence and 
density of gametocytes, as well as the duration of game-
tocyte carriage, although the effect was transient as it did 
not prevent emergence of mature gametocytes at day 28 
after treatment (35). Another study in an area with highly 
seasonal but intense transmission in The Gambia showed 
that MDA with a single dose of artesunate combined with 
sulfadoxine-pyrimethamine failed to interrupt transmis-
sion overall, but incidence in the ﬁ  rst 2 months was sig-
niﬁ  cantly lower in treated villages than in control villages 
(36). The failure of MDA to interrupt transmission in the 
longer term was attributed to the high entomologic inoc-
ulation rate in the area. Nevertheless, MDA with a full 
therapeutic dose of ACT can likely play a major role in 
the control of epidemics and malaria in areas with a short 
transmission season (32).
Treatment of patients with fever, whether at health 
facilities or as part of epidemic control, presents the chal-
lenge of balancing costs in time and other resources with 
accuracy of clinical diagnosis. This diagnostic method is 
particularly less accurate in areas of low endemicity than 
in areas of high endemicity (37), although sensitivity and 
speciﬁ  city tend to increase during transmission seasons 
(38). As a result, overdiagnosis of malaria in areas of low 
transmission remains a major problem, especially when 
expensive ACT drugs are to be used for treating patients 
with fever. Furthermore, surveillance systems that rely 
entirely on data generated from health facilities without 
laboratory conﬁ  rmation can lead to false epidemic alerts 
(unpub. data).
The cost-effectiveness of rapid diagnostic tests in ep-
idemic situations in relation to the use of ACT has been 
compared with presumptive treatment by using a model 
based on actual cost data (39). The threshold prevalence 
beyond which treatment based on rapid diagnostic tests 
becomes more expensive than presumptive treatment was 
shown to be 21% for artesunate-amodiaquine and 55% for 
artemether-lumefantrine. During epidemics, the percentage 
of highland populations infected or incubating infection is 
usually higher than the threshold for artesunate-amodia-
quine. A recent study in western Kenyan highlands showed that nearly 44% of the sampled population were infected 
over a 10-week period during an epidemic, with adults 
and children similarly affected (40). These observations 
indicate that relatively less expensive ACT drugs such as 
artesunate-amodiaquine can be cost-effective when used in 
MFT without laboratory conﬁ  rmation. For large-scale epi-
demics when most of the population are either infectious or 
incubating the infection, MDA with relatively inexpensive 
ACT distributed once or repeated within 1–2 weeks can 
substantially reduce transmission.
The choice of treatment sites largely depends on the 
magnitude of the epidemic. Treatment at existing health 
facilities should be given special attention, and health ser-
vices should ensure that essential drugs for the treatment 
of both uncomplicated and severe malaria are in stock. In 
many situations, mobile treatment centers will be required 
to cover remote rural areas. In Kenya, mobile treatment 
teams could be assembled in 1 week through a provincial 
health system to control an outbreak in Uasin Gishu Dis-
trict (26).
Conclusion
Many countries still need to improve their technical 
and logistics capacity to deal with high demands in resourc-
es to prevent or contain malaria epidemics. Nevertheless, 
better targeting of interventions by using recent technologic 
advances in spatial analysis and risk mapping, optimal use 
of computing facilities in disease surveillance and efﬁ  cient 
use of information, and better preparedness especially in 
terms of antimalarial drug stocks will potentially provide 
a feasible means of effective epidemic control in many 
countries. In semi-arid areas, early warning methods using 
actual or probabilistic prediction of rainfall may be used 
for making decisions to implement prevention measures. In 
these areas, most vector control measures, including those 
targeting the aquatic stages of vectors, may be feasible and 
useful. In the highlands, anomalies in weather patterns, 
especially minimum temperatures, may be used as crude 
early warning indicators of malaria epidemics, mainly for 
preparedness purposes. However, the focus in these areas 
should be on early detection of abnormal incidence for 
rapid initiation of response. In normally malaria-free high-
lands, measures attempting to prevent transmission based 
on crude forecasts may not be cost-effective or feasible in 
most situations. At present, the use of IRS and other vector 
control measures in these areas should be limited to special 
situations where selective and timely application is feasible 
to contain proven, ongoing transmission. More research 
is required to increase our understanding of the genesis of 
epidemic malaria in the highlands and to develop better 
predictive models. Research should also focus on ways of 
developing local epidemic management capacities within 
the health service systems. The use of relatively inexpen-
sive ACT drugs such as artesunate-amodiaquine for MDA 
or MFT should be a primary strategy for rapidly reducing 
transmission in all epidemic situations.
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